Puregen Labs Acetaminophen

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with various conditions, including headache, toothache, muscular aches, the common cold, backache, minor pain from arthritis, and premenstrual and menstrual cramps. Additionally, it is indicated for the temporary reduction of fever.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children 12 years of age and older are advised to take 1 to 2 tablespoonfuls orally every 4 to 6 hours as needed. The maximum dosage should not exceed 6 tablespoonfuls within a 24-hour period.

For children under 12 years of age, the use of this medication is not recommended.

It is essential that patients do not exceed the directed dosage.

Contraindications

Use of this product is contraindicated in the following situations:

Patients should not use this product in conjunction with any other medication containing acetaminophen, whether prescription or nonprescription, due to the risk of acetaminophen overdose. If there is uncertainty regarding the presence of acetaminophen in other medications, consultation with a healthcare professional is advised.

This product is contraindicated in individuals with a known allergy to acetaminophen or any of the inactive ingredients contained within the formulation.

Warnings and Precautions

This product contains acetaminophen, which necessitates careful consideration of the following warnings and precautions to ensure safe use.

Liver Warning The maximum daily dose of this product is 90 mL within a 24-hour period. Severe liver damage may occur if the following conditions are met: exceeding 120 mL (4,000 mg of acetaminophen) in 24 hours, concurrent use with other medications containing acetaminophen, or consumption of three or more alcoholic drinks daily while using this product.

Allergy Alert Acetaminophen may induce skin reactions, which can manifest as skin reddening, blisters, or rash. Should any skin reaction occur, it is imperative to discontinue use immediately and seek medical assistance.

General Precautions Healthcare professionals should advise patients to consult a physician prior to use if they have a history of liver disease. Additionally, patients taking the anticoagulant warfarin should also seek medical advice before using this product.

Emergency Medical Help In the event of an overdose, it is crucial to obtain medical help or contact a Poison Control Center (1-800-222-1222) without delay.

Stop Taking and Call Your Doctor Patients should discontinue use and consult a healthcare provider if any of the following occur: pain worsens or persists beyond 10 days, fever intensifies or lasts more than 3 days, new symptoms arise, or if redness or swelling is observed, as these may indicate a serious condition.

Side Effects

Patients using this product should be aware of the potential for serious adverse reactions, particularly related to liver health and allergic skin responses.

Severe liver damage may occur if patients exceed the maximum daily dose of 90 mL (4,000 mg of acetaminophen) within a 24-hour period. This risk is heightened if patients take more than 120 mL in a day, use other medications containing acetaminophen concurrently, or consume three or more alcoholic drinks daily while using this product.

Additionally, patients should be vigilant for signs of allergic reactions, which may manifest as skin reddening, blisters, or rash. In the event of a skin reaction, it is imperative that patients discontinue use immediately and seek medical assistance.

Patients are advised to stop using the product and consult a healthcare professional if pain worsens or persists beyond 10 days, if fever intensifies or lasts more than 3 days, if new symptoms arise, or if there is any redness or swelling, as these may indicate a serious underlying condition.

Drug Interactions

Acetaminophen has the potential to interact with warfarin, which may lead to an increased risk of bleeding. When these two agents are used concurrently, it is advisable to monitor the International Normalized Ratio (INR) closely to ensure patient safety and appropriate anticoagulation management.

No additional drug interactions or interactions with laboratory tests have been reported.

Packaging & NDC

Below are the non-prescription pack sizes of Puregen Labs Acetaminophen (acetaminophen). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should not use this medication. For adolescents aged 12 years and older, the recommended dosage is 1 to 2 tablespoonfuls every 4 to 6 hours as needed, with a maximum of 6 tablespoonfuls in a 24-hour period. Caution is advised to ensure adherence to the dosing guidelines to prevent potential overdose.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully weighed, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure safe use during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring.

Hepatic Impairment

Patients with hepatic impairment should be closely monitored when using this product, which contains acetaminophen. The maximum daily dose for patients is 90 mL within a 24-hour period. It is critical to note that severe liver damage may occur if patients exceed the following limits:

• More than 120 mL (4,000 mg of acetaminophen) in 24 hours.

• Concurrent use with other medications that contain acetaminophen.

• Consumption of three or more alcoholic drinks daily while using this product.

Due to the potential for increased risk of liver damage, patients with compromised liver function should exercise caution and adhere strictly to the recommended dosage guidelines. Regular assessment of liver function may be warranted in these patients to ensure safety and prevent adverse effects.

Overdosage

In cases of overdosage, significant health risks are associated with excessive intake of acetaminophen. Specifically, the consumption of more than 120 ml (equivalent to 4,000 mg) within a 24-hour period can lead to severe liver damage.

Healthcare professionals should be vigilant in monitoring patients who may have ingested acetaminophen in excess of the recommended dosage. Symptoms of acetaminophen overdosage may not be immediately apparent and can manifest as nausea, vomiting, loss of appetite, confusion, or jaundice as liver damage progresses.

Management of acetaminophen overdosage involves prompt medical intervention. It is crucial to assess the patient's liver function and initiate treatment as necessary. The administration of N-acetylcysteine (NAC) is recommended as an antidote to mitigate liver injury, particularly if treatment is initiated within 8 to 10 hours of ingestion. Continuous monitoring of liver enzymes and overall patient status is essential to guide further management and ensure patient safety.

In summary, awareness of the risks associated with acetaminophen overdosage and timely intervention are critical in preventing severe hepatic complications.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

Postmarketing experience has identified rare cases of severe skin reactions associated with acetaminophen use. These reactions include Stevens-Johnson syndrome, toxic epidermal necrolysis, and acute generalized exanthematous pustulosis. Notably, these severe skin reactions may occur in patients who have no prior history of skin reactions to acetaminophen.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children. In the event of an overdose, patients should seek medical help or contact a Poison Control Center immediately at 1-800-222-1222.

Patients should be informed not to use this medication in conjunction with any other drug that contains acetaminophen, whether prescription or nonprescription. If patients are uncertain whether a drug contains acetaminophen, they should consult with a doctor or pharmacist.

It is essential to inform patients that they should not use this medication if they are allergic to acetaminophen or any of the inactive ingredients present in the product. Additionally, patients should be encouraged to ask a doctor before using this medication if they have liver disease or if they are taking the blood-thinning medication warfarin.

While using this product, patients must be cautioned not to exceed the recommended dose. They should be instructed to stop use and consult a doctor if their pain worsens or persists for more than 10 days, if their fever worsens or lasts more than 3 days, or if they experience any new symptoms. Furthermore, patients should be advised to discontinue use and seek medical advice if they notice any redness or swelling, as these may indicate a serious condition.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain integrity. It should be stored at a temperature range of 20°C to 25°C (68°F to 77°F), with permissible excursions between 15°C to 30°C (59°F to 86°F). It is essential to protect the product from light to prevent degradation. Once opened, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Puregen Labs Acetaminophen, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)